BACKGROUND: Respiratory syncytial virus (RSV) vaccine development for direct protection of young infants faces substantial obstacles. Assessing the potential of indirect protection using different strategies, such as targeting older children or mothers, requires knowledge of the source of infection to the infants. METHODS: We undertook a prospective study in rural Kenya. Households with a child born after the preceding RSV epidemic and ≥ 1 elder sibling were recruited. Nasopharyngeal swab samples were collected every 3-4 days irrespective of symptoms from all household members throughout the RSV season of 2009-2010 and tested for RSV using molecular techniques. RESULTS: From 451 participants in 44 households a total of 15 396 nasopharyngeal...
Background: Respiratory syncytial virus (RSV) is a major cause of community acquired severe respirat...
Background.Although necessary for developing a rationale for vaccination, the burden of severe respi...
The rate of decay and the subsequent antibody responses to RSV are poorly defined in young infants a...
Background. Respiratory syncytial virus (RSV) vaccine development for direct protection of young inf...
Households represent a setting of frequent and intense contacts and hence are conducive to the sprea...
Respiratory syncytial virus (RSV) is responsible for a significant burden of severe acute lower resp...
Introduction: Knowledge on RSV infection and disease is sparse in much of sub-Saharan Africa. Diseas...
Respiratory syncytial virus (RSV) is responsible for a significant burden of severe acute lower resp...
Respiratory syncytial virus is the leading cause of lower respiratory tract infection among infants....
Infants (under 1-year-old) are at most risk of life threatening respiratory syncytial virus (RSV) di...
BACKGROUND: In developing countries, there are few data that characterize the disease burden attribu...
Background. In developing countries, there are few data that characterize the disease burden attribu...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease and related ...
Infants (under 1-year-old) are at most risk of life threatening respiratory syncytial virus (RSV) di...
AbstractBackgroundSevere respiratory syncytial virus (RSV) disease occurs predominantly in children ...
Background: Respiratory syncytial virus (RSV) is a major cause of community acquired severe respirat...
Background.Although necessary for developing a rationale for vaccination, the burden of severe respi...
The rate of decay and the subsequent antibody responses to RSV are poorly defined in young infants a...
Background. Respiratory syncytial virus (RSV) vaccine development for direct protection of young inf...
Households represent a setting of frequent and intense contacts and hence are conducive to the sprea...
Respiratory syncytial virus (RSV) is responsible for a significant burden of severe acute lower resp...
Introduction: Knowledge on RSV infection and disease is sparse in much of sub-Saharan Africa. Diseas...
Respiratory syncytial virus (RSV) is responsible for a significant burden of severe acute lower resp...
Respiratory syncytial virus is the leading cause of lower respiratory tract infection among infants....
Infants (under 1-year-old) are at most risk of life threatening respiratory syncytial virus (RSV) di...
BACKGROUND: In developing countries, there are few data that characterize the disease burden attribu...
Background. In developing countries, there are few data that characterize the disease burden attribu...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease and related ...
Infants (under 1-year-old) are at most risk of life threatening respiratory syncytial virus (RSV) di...
AbstractBackgroundSevere respiratory syncytial virus (RSV) disease occurs predominantly in children ...
Background: Respiratory syncytial virus (RSV) is a major cause of community acquired severe respirat...
Background.Although necessary for developing a rationale for vaccination, the burden of severe respi...
The rate of decay and the subsequent antibody responses to RSV are poorly defined in young infants a...